Brief: Press release - Arch Biopartners says enters license agreement with University of Cincinnati for AB569
16/03/2016 07:00
March 16 (Reuters) - Arch Biopartners Inc ACH.V : * Press release - Arch Biopartners enters exclusive license agreement with University of Cincinnati for AB569 * Says Arch will pay UC a nominal one time fee for entering into the license * Source text (http://bit.ly/22l7oVQ) * Further company coverage ACH.V ((Bengaluru Newsroom; +1 646 223 8780))
Recent news on Arch Biopartners
See all newsBrief: Arch Biopartners To Expand Phase Ii Cardiac Surgery-Associated Acute Kidney Injury Trial To The US
Brief: Arch Biopartners Closes Non-Brokered Private Placement
Brief: Arch Strengthens Its Position As A Leading Kidney Therapeutics Company With The Acquisition Of A Breakthrough Platform To Develop New Drugs Targeting Chronic Kidney Disease (Ckd)
Brief: Arch Biopartners Closes Non-Brokered Private Placement
Brief: Arch Biopartners Announces Ontario Research Ethics Board Approval To Start Phase II Trial For LSALT Peptide